Loopbaan van Lisa M. Bell
Eerdere bekende functies van Lisa M. Bell
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| COHERUS BIOSCIENCES, INC. | Algemeen Adviseur | 12-05-2014 | 01-12-2017 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Algemeen Adviseur | - | - |
| BIOMARIN PHARMACEUTICAL INC. | Algemeen Adviseur | - | - |
Opleiding van Lisa M. Bell
| University of California, Berkeley | Doctorate Degree |
| Boston University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Israël | 2 |
Operationeel
| General Counsel | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| COHERUS BIOSCIENCES, INC. | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
- Beurs
- Insiders
- Lisa M. Bell
- Ervaring
